These days, meetings of top industry executives seem to occur at the rate of at least one a week. And so the meeting that took place on May 19-20 at a hotel in suburban Washington, D.C., might have been completely unremarkable, except that it brought together top executives from the chemical industry with their counterparts in the biotechnology industry for what its sponsors―the American Chemical Society and Biotechnology Industry Organization (BIO)―billed as a CTO (as in chief technology officer) Summit.
展开▼
